- Home
- EYPT vs TXO Comparison
EYPT vs TXO Comparison
Compare EYPT & TXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYPT
- TXO
- Stock Information
- Founded
- EYPT 1987
- TXO 2012
- Country
- EYPT United States
- TXO United States
- Employees
- EYPT N/A
- TXO N/A
- Industry
- EYPT Biotechnology: Laboratory Analytical Instruments
- TXO Oil & Gas Production
- Sector
- EYPT Industrials
- TXO Energy
- Exchange
- EYPT Nasdaq
- TXO Nasdaq
- Market Cap
- EYPT 741.0M
- TXO 788.9M
- IPO Year
- EYPT 2005
- TXO 2023
- Fundamental
- Price
- EYPT $13.76
- TXO $14.05
- Analyst Decision
- EYPT Strong Buy
- TXO Strong Buy
- Analyst Count
- EYPT 6
- TXO 2
- Target Price
- EYPT $25.83
- TXO $21.50
- AVG Volume (30 Days)
- EYPT 823.7K
- TXO 142.9K
- Earning Date
- EYPT 11-06-2025
- TXO 11-04-2025
- Dividend Yield
- EYPT N/A
- TXO 17.15%
- EPS Growth
- EYPT N/A
- TXO N/A
- EPS
- EYPT N/A
- TXO 0.30
- Revenue
- EYPT $51,898,000.00
- TXO $332,267,000.00
- Revenue This Year
- EYPT N/A
- TXO $31.08
- Revenue Next Year
- EYPT N/A
- TXO $11.32
- P/E Ratio
- EYPT N/A
- TXO $47.27
- Revenue Growth
- EYPT 2.99
- TXO 15.94
- 52 Week Low
- EYPT $3.91
- TXO $13.28
- 52 Week High
- EYPT $14.42
- TXO $20.70
- Technical
- Relative Strength Index (RSI)
- EYPT 66.97
- TXO 50.03
- Support Level
- EYPT $12.88
- TXO $13.42
- Resistance Level
- EYPT $14.15
- TXO $13.88
- Average True Range (ATR)
- EYPT 0.76
- TXO 0.29
- MACD
- EYPT 0.02
- TXO 0.08
- Stochastic Oscillator
- EYPT 79.11
- TXO 83.78
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
About TXO TXO Partners L.P.
TXO Partners LP is focused on the acquisition, development, optimization, and exploitation of oil, natural gas, and natural gas liquid reserves in North America.